Japanese Companies Sue Government Over New OTC Online Purchase Regulation
This article was originally published in PharmAsia News
Executive Summary
Two major online marketing companies in Japan, Kenko.com and Wellnet filed May 25 a lawsuit against the government over online purchase regulations for over-the-counter drugs. A ministerial ordinance from the Ministry of Health, Labor and Welfare requires face-to-face transactions for OTC drugs categorized as class 1 and 2. A pharmacist explanation is required for class 1 drugs, and an explanation from a pharmacist or a registered seller is required for class 2 drugs. Japanese online marketers consider the regulation an actual ban on the online purchase of the drugs. The two companies claim that the government's decision to ban Internet sales went beyond its jurisdiction. (Click here for more - Japanese language
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.